• CHIR-99021: Practical GSK-3 Workflows

  2026-08-12

  CHIR-99021 (CT99021) provides a selective way to activate canonical Wnt signaling while preserving clear experimental control over concentration, timing, and cell state. This guide translates its mechanism into reproducible pluripotency, differentiation, assay-design, and troubleshooting workflows.

• IRG1–Itaconic Acid Control of TBK1 and IFN-I

  2026-08-12

  Chai et al. identify an IRG1–itaconic acid metabolic feedback pathway that restrains excessive TBK1-dependent type I interferon signaling through covalent modification of TBK1 at Cys605. The study also introduces ITA-5 and ITA-9 as itaconic acid-based inhibitors with potential relevance to diseases driven by IFN-I hyperinflammation.

• EDI3 in HER2-Therapy-Resistant Breast Cancer

  2026-08-11

  Keller et al. identify the glycerophosphodiesterase EDI3/GPCPD1 as a metabolic vulnerability in estrogen receptor-negative, HER2-positive breast cancer models with resistance to HER2-targeted therapy. By combining patient-tissue analyses, signaling experiments, genetic depletion, dipyridamole-based inhibition, and xenograft studies, the work provides a rationale for further testing EDI3-directed strategies.

• QPRT Drives Breast Cancer Invasion via Myosin Light Chain

  2026-08-11

  The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a functional promoter of breast cancer migration and invasion, linking NAD+ metabolism to myosin light chain phosphorylation. Genetic perturbation and inhibitor-based pathway analysis implicate purinergic, Rho–ROCK, PLC, and MLCK signaling, while also highlighting the limits of interpreting pharmacological inhibition as definitive pathway proof.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-10

  The reference study develops a nonviral lipid nanoparticle platform for intravesical delivery of chemically modified p21 mRNA, addressing both tumor-suppressor loss and the delivery barriers associated with systemic mRNA therapy. In bladder cancer models, localized p21 restoration inhibited tumor growth, altered cell-cycle and DNA-damage signaling, and limited systemic exposure, while also highlighting important translational questions about formulation, dosing, and model-to-human transfer.

• Rapamycin, Lipophagy, and Lipotoxicity in Salmon Cells

  2026-08-09

  Phadwal and colleagues show that rapamycin-induced autophagy promotes lipid-droplet turnover and reduces lipotoxic features in Atlantic salmon SHK-1 cells. By combining lipidomics, proteomics, and cellular evidence, the study identifies altered unsaturated triacylglycerol storage and possible autophagic targeting of lipid-regulatory proteins, providing a useful framework for fish lipid-metabolism research.

• Protoporphyrin IX Workflows for Heme and Ferroptosis

  2026-08-08

  Protoporphyrin IX connects heme formation, iron handling, and photodynamic assay design, while its unusual solubility profile demands disciplined formulation and light controls. This guide translates the METTL16–SENP3–LTF ferroptosis findings into practical, clearly bounded experiments for hepatocellular carcinoma research.

• SM-102: From LNP Mechanism to Translational Strategy

  2026-08-07

  SM-102 is more than an LNP raw material: it is a formulation variable that links endosomal biology, tissue-specific delivery, and translational execution. This article examines how SM-102 can inform mRNA vaccine development and localized therapeutic mRNA programs, using recent bladder cancer evidence to define opportunities, boundaries, and practical next steps.

• FPH1 (BRD-6125): Redefining Hepatocyte Expansion in Modern A

  2026-08-07

  Discover how FPH1 (BRD-6125) advances hepatocyte proliferation and functional maturation in cell-based assays. This article provides deep technical insights and unique protocol guidance for primary human hepatocyte culture.

• Tin Mesoporphyrin IX (chloride): Precision Heme Oxygenase In

  2026-08-06

  Tin Mesoporphyrin IX (chloride) is a nanomolar, competitive heme oxygenase inhibitor validated in metabolic and antiviral research. APExBIO’s C5606 enables reproducible control of heme catabolism, with rigorous benchmarks for in vitro and in vivo studies.

• 3D Organoid–CAF Models Reveal Stroma-Driven PDAC Chemoresist

  2026-08-06

  Schuth et al. present a patient-specific 3D co-culture system combining pancreatic tumor organoids and matched cancer-associated fibroblasts, enabling precise investigation of stromal contributions to chemoresistance in PDAC. Their findings highlight the necessity of stromal elements for physiologically relevant drug screening and implicate CAF-induced EMT as a key mechanism.

• Dissecting Proliferation and Death in In Vitro Cancer Drug T

  2026-08-05

  Schwartz’s dissertation establishes a refined framework for evaluating drug responses in cancer cell models by distinguishing between proliferative arrest and cell death. This distinction enables more precise mechanistic interpretation and better informs preclinical drug assessment strategies.

• Tin Mesoporphyrin IX: Advancing Heme Oxygenase Inhibition As

  2026-08-05

  Tin Mesoporphyrin IX (chloride) offers unmatched specificity and reproducibility for dissecting heme oxygenase pathways in metabolic and virology research. Its nanomolar potency and proven in vivo performance set a new standard for targeted modulation of heme catabolism.

• Afatinib (SKU A4746): Reliable EGFR/HER2 Inhibition in Cance

  2026-08-04

  This authoritative guide addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays using Afatinib (SKU A4746). Supported by recent assembloid model evidence, it provides scenario-driven insights for selecting, optimizing, and interpreting results with this irreversible ErbB family tyrosine kinase inhibitor. Bench scientists gain practical value for experimental reproducibility and translational research.

• L-Phenylephrine: Selective α1A Adrenergic Agonist for Resear

  2026-08-04

  L-Phenylephrine is a selective adrenergic α1A receptor agonist widely used in cardiovascular and neurobiological research. Its high receptor specificity, ability to modulate gene expression, and reproducible physiological effects make it a benchmark tool for dissecting α1-adrenergic signaling pathways.

7896 records 3/527 page Previous Next 12345 下5页 Last page